---
schema_version: "secwatch.filing_event.v1"
accession: "0001428336-23-000016"
form_type: "8-K"
ticker: "HQY"
cik: "0001428336"
company_name: "HEALTHEQUITY, INC."
filed_at: "2023-04-13T23:59:59+00:00"
generated_at: "2026-06-17T02:34:30.618139+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Ian Sacks to not stand for re-election at HealthEquity 2023 annual meeting

## Summary
- Director Ian Sacks notified HealthEquity Board on April 13, 2023 of decision not to stand for re-election at 2023 Annual Meeting.
- Board will reduce size from 12 to 11 directors effective immediately after June 22, 2023 annual meeting.
- Ian Sacks will continue to serve as director until the annual meeting on June 22, 2023.

## SEC filing metadata
- accession: 0001428336-23-000016
- form_type: 8-K
- ticker: HQY
- cik: 0001428336
- company_name: HEALTHEQUITY, INC.
- filed_at: 2023-04-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000016/0001428336-23-000016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000016/hqy-20230413.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001428336-23-000016
- JSON: https://secwatch.observer/filing/0001428336-23-000016.json
- Plain text: https://secwatch.observer/filing/0001428336-23-000016.txt

## Key facts
- Executive change
  Ian Sacks departed as Director at HEALTHEQUITY, INC..
  - Action: not stand for re-election
  - Role: Director
  source text: Ian Sacks, who on April 13, 2023 notified the Board of his decision not to stand for re-election at the 2023 Annual Meeting of Stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000016/0001428336-23-000016-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.